Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

J A Kemp Webinar: Drafting and Prosecuting Applications for Polymorphs of Drug Compounds at the EPO

Patents directed to polymorphs of pharmaceutical compounds can be of significant commercial importance. However, care needs to be taken both during drafting and prosecution to increase the chance of success at the European Patent Office. This webinar will discuss some of the issues faced for patent applications for polymorphs and how those issues can be addressed at the EPO, as well as looking at some recent case law.

Topics will include:

Neuroprotection Symposium: The Quest for New Medicines to Slow the Progression of Disability in Neurodegenerative Disorders

Neurodegenerative disorders affect the structure and function of the central nervous system, leading to the progressive loss of cognitive, motor, and sensory abilities. They include Alzheimer's disease, Parkinson’s disease, motor neuron disease, multiple sclerosis, Huntington’s disease, stroke and traumatic brain injury.

BIO 2025

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.

Unlocking Your Time: A Delegation Masterclass

Join us for an insightful workshop on the art of delegation. This learned skill is the key to unlocking increased productivity as well as personal growth for leaders, senior managers and entrepreneurs. This interactive, informal session is designed to help you master skills that will lead to effective leadership and build trust within your team, empowering others to take ownership. Practical tips will help you prioritise tasks, improve time management, foster collaboration and elevate your leadership potential with smart delegation gaining the headspace you need to move forward.

Microbiotica Announces First Patient Dosed in Its International Phase 1b Trial, Melody-1 of Mb097 Precision Microbiome Co-therapy in Advanced Melanoma

Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab)

Cambridge, UK – 7 October 2024: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that the first patient has been dosed in its advanced melanoma (MELODY-1) trial. This international trial is due to recruit up to 40 patients at clinical centres in the UK, France, Italy and Spain. Initial data readouts are expected by the end of 2025.